Deoxyspergualin neither counteracts lipopolysaccharide (LPS) or Staphylococcus aureus enterotoxin-B (SEB) induced lethality in mice nor does it modulate the release of tumor necrosis factor-α

Immunology Letters

Volumn 61, Issue 1, 1998, Pages 63-66

  Di Marco, R ^a   Zaccone, P ^a   Condorelli, L ^a   Leonardi, C ^a   Caccamo, F ^a   Di Mauro, C ^a   Meroni, P ^b   Nicoletti, F ^c  

^a UNIVERSITY OF CATANIA   (Italy)

^b Policlinico IRCS   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Deoxyspergualin; Sepsis; Sodium fusidate; Tumor necrosis factor

Indexed keywords

15 DEOXYSPERGUALIN; ENDOTOXIN; EXOTOXIN; FUSIDATE SODIUM; GALACTOSAMINE; IMMUNOSUPPRESSIVE AGENT; LIPOPOLYSACCHARIDE; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTOXEMIA; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; LETHALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SURVIVAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ENDOTOXEMIA; ENTEROTOXINS; FEMALE; GUANIDINES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; SURVIVAL RATE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031948863     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(97)00160-0     Document Type: Article

References (21)

1. Takeuchi T., Iinuma H., Kunimoto S., Masuda T., Ishizuka M., Takeuchi M., Hamada M., Naganawa H.J., Kondo S., Umezawa H. A new antitumor antibiotic, spergualin: isolation and antitumor activity. J. Antibiot. 34:1981;1619.
2. Takagishi K., Yamamoto M., Maeda K., Nishimura A., Yonemoto K., Hotokebuchi T., Kaibaba N. Effects of deoxyspergualin on collagen arthritis in mice. Clin. Immunol. Immunopathol. 56:1990;81.
3. Ito S., Ueno M., Arakawa M., Sauto T., Aoyagi T., Fujiwara M. Therapeutic effects of 15-deoxyspergualin on the progression of lupus nephritis in MRL-mice. I. Immunopathological analyses. Clin. Exp. Immunol. 81:1990;446.
4. Mochizuku M., Kawashima H. Effects of FK506, 15-deoxyspergualin and cyclosporine on experimental autoimmune uveoretinitis in the rat. Autoimmunity. 8:1990;37.
5. Nicoletti F., Meroni P.L., Di Marco R., Grass S., Barcellini W., Borghi M.O., Lunetta M., Mughini L., Menta R., Schorlemmer H.U., Zanussi C. The effects of deoxyspergualin on the development of diabetes in diabetes-prone BB rats. Scand. J. Immunol. 36:1992;145.
6. Nicoletti F., Borghi M.O., Meroni P.L., Barcellini W., Fain C., Di Marco R., Menta R., Schorlemmer H.U., Bruno G., Magro G., Grasso S. Prevention of cyclophosphamide-induced diabetes in the NOD/Whei mouse with deoxyspergualin. Clin. Exp. Immunol. 91:1993;232.
7. Nicoletti F., Di Marco R., Barcellini W., Borghi M.O., Lunetta M., Mughini L., Meroni P.L. Protection from experimental autoimmune thyroiditis in CBA mice with the novel immunosuppressant deoxyspergualin. Scand. J. Immunol. 39:1994;333.
8. Lan H.Y., Nikolic-Paterson D.J., Zarama M., Kerr P.G., Atkins R.C. Suppression of pulmunary injury in experimental Goodpasture's syndrome by deoxyspergaulin (15-deoxyspergualin). Clin. Exp. Immunol. 95:1994;502.
9. Jung S., Toyka K.V., Hartung H.P. Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous central system in the Lewis rat. Clin. Exp. Immunol. 98:1994;494.
10. Reichespurner H., Hildebrant A., Human P.A., Bohem D.H., Rose A.G., Odell J.A., Reichart B., Schorlemmer H.U. 15-deoxyspergualin for induction of graft nonreactivity after cardiac and renal allotransplantation in primates. Transplantation. 50:1990;181.
11. Nadler S.G., Tepper M.A., Schatcter B., Mazzucco C. Interaction of the immunosuppressant deoxyspergualin with a member of the HSP 70 family of heat shock protein. Science. 258:1993;484.
12. Nishimura K., Tokunaga T. Mechanism of action of 15-deoxyspergualin. I. Suppressive effect on the induction of alloreactive secondary cytotoxic T lymphocytes in vivo and in vitro. Immunology. 68:1989;66.
13. Nicoletti F., Borghi M.O., Barcellini W., Fain C., Beltrami B., Del Papa N., Schorlemmer H.U., Mottola L., Meroni P.L. Immunosuppressive activity of 15-deoxyspergualin on normal and autoimmune peripheral blood mononuclear cells. Eur. J. Pharmacol. 311:1996;213.
14. Hoeger P.H., Tepper M.A., Faith A. , J.A. Higgins, J.R. Lamb, R.S. Geha, Immunosuppressant deoxyspergualin inhibits antigen processing by monocytes. J. Immunol. 153:1994;3908.
15. Wang B., Benoist C., Mathis D. The immunosuppressant 1,5-deoxyspergualin reveals commonality between preT and preB cell differentiation. J. Exp. Med. 183:1996;2427.
16. Asano K., Muramatsu K., Ikeda K., Okamoto K. Inhibitory action of deoxyspergualin on effector/memory T cell generation during Hymenolepis nana infection in mice. Immunol. Lett. 53:1996;51.
17. Makino M., Fujiwara M., Watanabe H., Aoyagi T., Umezawa H. Immunosuppressive activities of deoxyspergualin. II. The effect on the antibody responses. Immunopharmacology. 14:1987;115.
18. Kerr P.G., Nikolic-Paterson D.J., Lan H.Y., Tesch G., Rainone S., Atkins R.C. Deoxyspergaulin suppresses local macrophage proliferation in rat renal allograft rejection. Transplantation. 58:1994;596.
19. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P.H., Wagner H. T cell mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role for tumor necrosis factor. J. Exp. Med. 175:1992;91.
20. Nicoletti F., Zaccone P., Di Marco R., Magro G., Grasso S., Morrone S., Santoni A., Tempera G., Meroni P.L., Bendtzen K. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. Immunology. 65:1995;645.
21. Gonzalo J.A., Gonzalez-Garcia A., Kalland T., Hedlund G., Martinez C., Kroemer G., Linomide G. A novel immunomodulator that prevents death in four models of septic shock. Eur. J. Immunol. 23:1993;2372.